Stay updated with breaking news from Precision Library. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
30.08.2022 - – Topline data for anti-CTLA-4 antibody, ADG116, shows compelling clinical safety and complete and partial responses as both a single agent and in combination with anti-PD-1 therapy; results to be presented at SITC 2022 – – Masked, anti-CTLA-4 ...
- Total potential transaction value of $2.5 billion plus royalties - SAN DIEGO and SUZHOU, China, March 02, 2022 -- Adagene Inc. , a company transforming the discovery and... | March 2, 2022
SAN DIEGO and SUZHOU, China, Jan. 27, 2022 -- Adagene Inc. , a company transforming the discovery and development of novel antibody-based therapies, today announced the first patient has been... | January 27, 2022